Red Flags Detected

  • Going Concern (worsened) — Accumulated deficit increased from $264.8M to $284.7M; cash dropped from $6.7M to $2.2M; survival now explicitly depends on closing Oramed transaction.
NASDAQ: LFWD Lifeward Ltd. 10-K

Lifeward secures Oramed financing, cedes 49.99% equity; FDA clears ReWalk 7 amid cash burn

Filed March 18, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 7, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade LFWD commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.